acrolein has been researched along with Hematuria in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Harahap, Y; Melhan, M; Muhammad, C; Purwanto, DJ; Yanuar, A | 1 |
Bryant, BM; Ford, HT; Jarman, M; Smith, IE | 1 |
Saiers, JH; Slavik, M | 1 |
Gurtoo, HL; Hipkens, JH; Sharma, SD | 1 |
1 trial(s) available for acrolein and Hematuria
Article | Year |
---|---|
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
Topics: Acrolein; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Female; Hematuria; Humans; Ifosfamide; Kinetics; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Phosphoramide Mustards; Urinary Bladder | 1980 |
3 other study(ies) available for acrolein and Hematuria
Article | Year |
---|---|
Quantification of 3-Hydroxypropyl Mercapturic Acid in the Urine of Patients with Breast Cancer to Monitor Cyclophosphamide Toxicity.
Topics: Acetylcysteine; Acrolein; Adult; Alkylating Agents; Biomarkers; Breast Neoplasms; Chromatography, Liquid; Cyclophosphamide; Female; Hematuria; Humans; Middle Aged; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2020 |
Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.
Topics: Acetylcysteine; Acrolein; Adenocarcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Cystitis; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Hematuria; Humans; Ifosfamide; Lung Neoplasms | 1983 |
Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.
Topics: Acrolein; Alanine; Animals; Body Weight; Carcinoma 256, Walker; Cyclophosphamide; Cysteine; Female; Glutathione; Hematuria; Infusions, Parenteral; Liver; Male; Mice; Rats; Time Factors | 1981 |